Cargando…
PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment
Programmed death-ligand 1 (PD-L1) is an immune checkpoint molecule that can regulate immune responses in the tumor microenvironment (TME); however, the clinical applications of PD-L1 in early-stage colorectal cancer (CRC) remain unclear. In this study, we aimed to investigate the relationship betwee...
Autores principales: | Chung, Bing-Syuan, Liao, I-Chuang, Lin, Peng-Chan, Wu, Shang-Yin, Kang, Jui-Wen, Lin, Bo-Wen, Chen, Po-Chuan, Chan, Ren-Hao, Lee, Chung-Ta, Shen, Meng-Ru, Chen, Shang-Hung, Yeh, Yu-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655444/ https://www.ncbi.nlm.nih.gov/pubmed/36362062 http://dx.doi.org/10.3390/ijms232113277 |
Ejemplares similares
-
Treatment monitoring of colorectal cancer by integrated analysis of plasma concentration and sequencing of circulating tumor DNA
por: Yeh, Yu-Min, et al.
Publicado: (2020) -
Comprehensive assessment of HER2 alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance
por: Yeh, Yu-Min, et al.
Publicado: (2019) -
A Prediction Model for Tumor Recurrence in Stage II–III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling
por: Chen, Po-Chuan, et al.
Publicado: (2022) -
Clinical Utility of a Cell-Free DNA Assay in Patients With Colorectal Cancer
por: Chan, Ren-Hao, et al.
Publicado: (2021) -
Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Huang, Yi-Hsuan, et al.
Publicado: (2021)